Pharmaceutical

Talaris Therapeutics to merge with Tourmaline Bio

Talaris Therapeutics has entered into a definitive agreement to merge with late-stage clinical biotechnology company Tourmaline Bio.

Jun 23, 2023 - 20:00
Talaris Therapeutics to merge with Tourmaline Bio
Talaris Therapeutics has entered into a definitive agreement to merge with late-stage clinical biotechnology company Tourmaline Bio.
Read the original article

Tags:

Previous Article

Erasca’s ERAS-801 gains FDA orphan drug designation for glioblastoma

Next Article

Kymera’s novel MDM2 degrader granted orphan designation for AML

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Trump demands the U.S. pay no more for drugs than other countries … again

STAT+: Trump demands the U.S. pay no more for drugs tha...

Jun 28, 2023

Insilico teams up with Menarini for breast cancer KAT6 inhibitor

Insilico teams up with Menarini for breast cancer KAT6 ...

Jan 5, 2024

DF-4101 by AbbVie for Renal Cell Carcinoma: Likelihood ...

Apr 21, 2024